CONAVI MEDICAL CORP (CNVI.CA) Stock Income Statement
TSX-V:CNVI - TSX Venture Exchange - CA2059531020 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.69M | 24.11M | 0.00 | 27.48M | 20.00M | |||
| Operating Expenses | 16.58M | 11.87M | 61.22M | 69.85M | 15.80M | |||
| Research and Development | 8.47M | 439.00K | 45.14M | 51.90M | 7.94M | |||
| Selling, General, and Administrative Expenses | 7.47M | 11.18M | 14.91M | 16.99M | 7.63M | |||
| Operating Income | -9.35M | 12.24M | -61.22M | -42.37M | 4.20M | |||
| Interest Income/Expense | 33.00K | 633.20K | 6.14M | 21.31M | -29.04M | |||
| Other Income/Expense | N/A | 143.60K | 0.00 | 827.30K | -1.82M | |||
| Non Recurring Items | -4.86M | -3.80M | -3.17M | 0.00 | 2.47M | |||
| Income Before Taxes | -14.18M | 9.54M | -58.25M | -20.24M | -24.18M | |||
| Income Tax | N/A | 32.80K | -76.60K | 76.60K | N/A | |||
| Net Income | -14.18M | 9.51M | -58.18M | -20.32M | -24.18M | |||
| EBITDA | N/A | 12.49M | -60.05M | -41.42M | 4.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.13 | 0.08 | -0.52 | -0.19 | -0.36 | |||
| Statistics | ||||||||
| Profit Margin | -163.17% | 39.43% | N/A | -73.95% | -120.90% | |||
| Operating Profit Margin | -107.58% | 50.75% | N/A | -154.22% | 21.00% | |||
All data in CAD